Email this article to a friend
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
-
* Corresponding author: Anja Strangfeld Strangfeld@drfz.de
Arthritis Research & Therapy 2010, 12:R5 doi:10.1186/ar2904